Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have gained considerable attention in recent years as promising therapeutic agents for MASLD, particularly owing to their well-established efficacy in treating type 2 diabetes mellitus (T2DM) and obesity, conditions closely implicated to MASLD pathogenesis (2, 5)
However, anything that alters saliva production, oral pH, or blood flow to the oral mucosa could theoretically affect GLP-1 drop absorption
Counsel patients to report symptoms of thyroid tumors (e.g., a lump in the neck, hoarseness, dysphagia, or dyspnea) to their physician [see Boxed Warning, Warnings and Precautions ( 5.1 )]
Factors Affecting Shelf Life Proper storage conditions play a big role in how long compounded semaglutide lasts
Mazdutide has been approved in China for long-term weight management in adults with overweight or obesity, even without type 2 diabetes in eligible patients.